Sub-30 Second Disintegration
Engineered with specialized croscarmellose and microcrystalline matrices that dissolve smoothly on the tongue within 30 seconds, enabling fast mucosal uptake without swallowing discomfort.
DELOTRIL-1 is a high-potency Clonazepam Mouth Dissolving Tablets IP 1 mg formulation by Blessme, the dedicated neuro-psychiatric division of Dellwich Lifescience LLP. Formulated with rapid-melt oral disintegration technology, DELOTRIL-1 provides swift sublingual dissolution and sustained symptom control for severe panic disorder, chronic agoraphobia, and refractory seizure conditions across India.

Detailed pharmaceutical specifications, active API monograph compliance, fast-melt characteristics, and packaging details for DELOTRIL-1.
Clonazepam Mouth Dissolving Tablets IP 1 mg (DELOTRIL-1) is a high-potency benzodiazepine oral formulation engineered to dissolve rapidly on the tongue without water. Provides robust control for moderate-to-severe panic disorder, acute anxiety crises, and seizure maintenance under expert medical supervision.
Comprehensive clinical and commercial guide on Clonazepam Mouth Dissolving Tablets IP 1 mg, marketed as DELOTRIL-1 by Blessme (Dellwich Lifescience LLP). Features receptor neurochemistry, clinical indications, comparative dosing, and B2B pharmaceutical distribution across India.
Clonazepam MD tablet 1 mg is an intensified clinical strength of Clonazepam IP formulated in an advanced orally disintegrating matrix. When lower dosages fail to adequately suppress severe panic attacks or stabilize refractory seizures, the 1 mg formulation delivers the necessary therapeutic potency.
In emergency psychiatric practice, a patient experiencing severe panic paroxysms may struggle with swallowing conventional tablets. DELOTRIL-1 dissolves smoothly on the tongue within 30 seconds upon contact with saliva, initiating fast mucosal uptake and clinical tranquilization without liquid administration.
Clonazepam MD tablet uses for the 1 mg strength focus on complex, high-severity neurological and psychiatric conditions:
Clonazepam 1 mg acts as a high-potency positive allosteric modulator on the GABAA receptor complex in the central nervous system. By enhancing the binding of gamma-aminobutyric acid (GABA), it increases the opening frequency of chloride ion channels, causing significant hyperpolarization of neuronal membranes.
This mechanism suppresses paroxysmal electrical firing in the amygdaloid nuclei, cortical fear networks, and thalamocortical circuits. The Mouth Dissolving (MD) formulation allows a portion of the drug to be absorbed sublingually and buccally, facilitating rapid systemic entry and symptom relief during intense panic paroxysms.
The DELOTRIL portfolio provides tiered therapeutic options for individual patient requirements:
DELOTRIL-1 must be administered under strict medical supervision:
Among established brands in India (Clonafit, Zapiz, Epitril), DELOTRIL-1 by Blessme has earned clinical trust for its reliability and commercial value:
Essential clinical warnings for healthcare professionals and patients:
Clonazepam 1 mg is a high-potency benzodiazepine with significant potential for habit formation, tolerance, and physical dependence. Long-term use requires careful clinical monitoring. DELOTRIL-1 is supplied strictly against a valid medical prescription from a registered medical practitioner.
DELOTRIL-1 is manufactured in advanced automated pharmaceutical facilities adhering to WHO-GMP, ISO 9001:2015, and Schedule M standards, ensuring exceptional fast-melt uniformity and batch-to-batch consistency.
Engineered with specialized croscarmellose and microcrystalline matrices that dissolve smoothly on the tongue within 30 seconds, enabling fast mucosal uptake without swallowing discomfort.
Encased in 5x4x10 protective blister cavities that insulate the hygroscopic fast-melt tablet from ambient atmospheric moisture, heat, and physical crumbling.
Strict pharmacopoeial monograph assays confirm precise 1 mg Clonazepam IP content, rapid disintegration limits, and dissolution conformity batch after batch.
Produced in state-of-the-art clean-room compression suites adhering to WHO-GMP, ISO 9001:2015, and Good Laboratory Practices (GLP) with automated environmental controls.
As a Schedule H controlled benzodiazepine medication, Clonazepam MD requires responsible clinical oversight, patient counseling, and adherence to prescription mandates.
DELOTRIL-1 contains Clonazepam IP 1 mg. To be sold by retail on the prescription of a Registered Medical Practitioner only. Do not exceed prescribed duration. Caution is advised when driving motor vehicles or handling complex machinery.
Approved neurological and psychiatric indications for Clonazepam MD 1 mg (DELOTRIL-1):
Key pharmacokinetic parameters and patient monitoring guidelines:
Dellwich Lifescience LLP is an established pharmaceutical company based in Science City, Ahmedabad, Gujarat, dedicated to advanced formulation technology, uncompromising quality assurance, and ethical healthcare supply. Through our specialized neurology division, Blessme, we manufacture and market superior neuro-psychiatric treatments, including DELOTRIL-1 (Clonazepam MD Tablets IP 1 mg).
We support PCD pharma franchise partners, hospital supply chains, and contract manufacturing clients across India with guaranteed supply security, validated product dossiers, and prompt dispatch.
Whether you are seeking DELOTRIL-1 (Clonazepam MD Tablets IP 1 mg) for district monopoly PCD franchise distribution, third-party contract manufacturing, or hospital bulk procurement, Dellwich Lifescience LLP delivers dependable supply and competitive trade margins.
Secure exclusive district-level distribution rights for DELOTRIL-1 and the entire Blessme Neuro portfolio with promotional visual aids, doctor samples, and attractive trade margins.
Contract manufacturing solutions for Clonazepam MD tablets (0.25 mg, 0.5 mg, 1 mg, 2 mg) with custom batch sizing, stability dossier preparation, and fast delivery timelines.
Direct supply partnerships for psychiatric hospitals, neuropsychiatric clinics, de-addiction centers, and state government health tenders across India.
When sourcing Clonazepam MD tablets IP or evaluating dependable clonazepam mouth dissolving tablet brands in India, DELOTRIL-1 by Blessme provides exceptional quality, rapid disintegration, and comprehensive B2B support.
Manufactured in WHO-GMP and ISO 9001:2015 certified units using pharmacopoeial grade Clonazepam IP, guaranteeing assay precision and fast-melt integrity.
Tamper-evident, moisture-resistant 5x4x10 blister strips protect fragile mouth-dissolving tablets from ambient humidity and transit friction.
Direct factory dispatch from Science City, Ahmedabad with GST invoicing, verified batch COA, and dependable logistics coverage across all Indian states.
Exclusive district-level franchise rights for DELOTRIL-1 and the entire Blessme Neuro portfolio with promotional tools, visual aids, and MR bags.
Certificates of Analysis (COA), stability testing data, and Material Safety Data Sheets (MSDS) readily available for institutional tenders and hospital audits.
Direct access to Dellwich Lifescience LLP product specialists for quick quotes, customized bulk supply inquiries, and dedicated customer assistance.
Authoritative answers to clinical, commercial, dosage, and regulatory questions regarding Clonazepam MD Tablets IP 1 mg.
Clonazepam MD tablet 1 mg (marketed under the brand name DELOTRIL-1 by Blessme division of Dellwich Lifescience LLP) is an advanced orally disintegrating benzodiazepine formulation. Each tablet contains Clonazepam IP 1 mg, designed to dissolve swiftly on the tongue without water for quick sublingual and pre-gastric absorption, effectively controlling severe panic attacks, debilitating anxiety, and convulsive disorders.
DELOTRIL-1 is clinically prescribed for: (1) moderate-to-severe panic disorder with agoraphobia unresponsive to lower doses; (2) severe generalized anxiety disorder (GAD) requiring potent daytime stabilization; (3) maintenance oral anticonvulsant therapy in myoclonic, absence, and refractory epilepsy syndromes; and (4) acute severe motor restlessness and akathisia under specialist psychiatric supervision.
Mouth Dissolving (MD) technology allows DELOTRIL-1 to melt completely on the tongue within 30 seconds upon contact with saliva. Patients experiencing intense panic paroxysms, choking sensations, or situational tremors can take the tablet immediately without needing water, providing rapid onset and superior patient compliance.
DELOTRIL-0.5 contains 0.5 mg Clonazepam IP, which is the standard starting and maintenance dose for typical panic disorder. DELOTRIL-1 contains 1 mg Clonazepam IP, prescribed when patients exhibit high tolerance, severe refractory panic symptoms, or when managing higher-threshold epileptic seizure syndromes.
Clonazepam 1 mg binds selectively with high affinity to benzodiazepine recognition sites on post-synaptic GABA_A receptors in the limbic system, thalamus, and cortex. This allosterically enhances gamma-aminobutyric acid (GABA) inhibitory transmission, opening chloride channels and causing sustained hyperpolarization that suppresses overactive panic and seizure neural pathways.
No. Clonazepam 1 mg is strictly categorized as a Schedule H prescription drug and controlled psychotropic substance in India. DELOTRIL-1 is supplied exclusively against a valid prescription issued by a registered medical practitioner.
DELOTRIL-1 is packaged in premium 5x4x10 blister strips (200 tablets per box) manufactured with moisture-barrier foils that prevent ambient humidity from softening the sensitive fast-melt tablet matrix.
DELOTRIL-1 is manufactured under WHO-GMP compliance and marketed by Dellwich Lifescience LLP, headquartered in Science City, Ahmedabad, Gujarat, under its dedicated neurology and psychiatry portfolio 'Blessme Neuro Products'.
Yes. Dellwich Lifescience LLP grants district-wise monopoly PCD pharma franchise opportunities for DELOTRIL-1 and the entire Blessme Neuro range, backed with visual aids, product cards, promotional inputs, and fast dispatch.
Place the tablet directly on the tongue. Allow it to dissolve in saliva and swallow without water. For severe panic disorder, dosage is typically titrated from 0.5 mg up to 1 mg daily in divided doses. Dosage must strictly be adjusted and tapered under medical direction.
Common adverse effects include drowsiness, motor ataxia, fatigue, dizziness, and cognitive slowing. Patients must avoid driving motor vehicles or operating heavy machinery. Long-term use requires gradual dosage tapering to prevent withdrawal symptoms.
DELOTRIL-1 provides cost-effective, high-quality healthcare with strong commercial margins. For trade price lists, PCD franchise terms, and institutional hospital supply quotes, contact Dellwich Lifescience LLP at +91-9909931992 or [email protected].
Yes. Dellwich Lifescience LLP provides third-party and contract manufacturing for Clonazepam MD tablets across all standard strengths (0.25 mg, 0.5 mg, 1 mg, 2 mg) in WHO-GMP certified facilities with complete stability validation.
Yes. Each batch of DELOTRIL-1 is accompanied by an authenticated Certificate of Analysis (COA), disintegration assay records, active IP testing, and Material Safety Data Sheet (MSDS).
Connect directly with Dellwich Lifescience LLP for trade pricing, district monopoly PCD rights, third-party manufacturing, or institutional hospital tender supplies.
Get bulk pricing, PCD monopoly availability, and technical documentation for Clonazepam MD 1 mg.